258 related articles for article (PubMed ID: 28281873)
1. Resolving the micro-heterogeneity and structural integrity of monoclonal antibodies by hybrid mass spectrometric approaches.
Yang Y; Wang G; Song T; Lebrilla CB; Heck AJR
MAbs; 2017; 9(4):638-645. PubMed ID: 28281873
[TBL] [Abstract][Full Text] [Related]
2. Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry.
Rosati S; Yang Y; Barendregt A; Heck AJ
Nat Protoc; 2014 Apr; 9(4):967-76. PubMed ID: 24675736
[TBL] [Abstract][Full Text] [Related]
3. Parallel development of chromatographic and mass-spectrometric methods for quantitative analysis of glycation on an IgG1 monoclonal antibody.
Viski K; Gengeliczki Z; Lenkey K; Baranyáné Ganzler K
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():198-204. PubMed ID: 27179993
[TBL] [Abstract][Full Text] [Related]
4. Extending the capabilities of intact-mass analyses to monoclonal immunoglobulins of the E-isotype (IgE).
Yang W; Ivanov DG; Kaltashov IA
MAbs; 2022; 14(1):2103906. PubMed ID: 35895856
[TBL] [Abstract][Full Text] [Related]
5. Performing native mass spectrometry analysis on therapeutic antibodies.
Thompson NJ; Rosati S; Heck AJ
Methods; 2014 Jan; 65(1):11-7. PubMed ID: 23688935
[TBL] [Abstract][Full Text] [Related]
6. In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap.
Rosati S; van den Bremer ET; Schuurman J; Parren PW; Kamerling JP; Heck AJ
MAbs; 2013; 5(6):917-24. PubMed ID: 23995615
[TBL] [Abstract][Full Text] [Related]
7. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
8. Rapid evaluation for heterogeneities in monoclonal antibodies by liquid chromatography/mass spectrometry with a column-switching system.
Kuribayashi R; Hashii N; Harazono A; Kawasaki N
J Pharm Biomed Anal; 2012; 67-68():1-9. PubMed ID: 22579601
[TBL] [Abstract][Full Text] [Related]
9. Exploring the analytical power of the QTOF MS platform to assess monoclonal antibodies quality attributes.
Gomes RA; Almeida C; Correia C; Guerreiro A; Simplício AL; Abreu IA; Alves PG
PLoS One; 2019; 14(7):e0219156. PubMed ID: 31291294
[TBL] [Abstract][Full Text] [Related]
10. Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization.
Terral G; Beck A; Cianférani S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():79-90. PubMed ID: 27108304
[TBL] [Abstract][Full Text] [Related]
11. Hyphenation of strong cation exchange chromatography to native mass spectrometry for high throughput online characterization of charge heterogeneity of therapeutic monoclonal antibodies.
Ma F; Raoufi F; Bailly MA; Fayadat-Dilman L; Tomazela D
MAbs; 2020; 12(1):1763762. PubMed ID: 32370592
[TBL] [Abstract][Full Text] [Related]
12. Optimisation of the use of sliding window deconvolution for comprehensive characterisation of trastuzumab and adalimumab charge variants by native high resolution mass spectrometry.
Millán-Martín S; Carillo S; Füssl F; Sutton J; Gazis P; Cook K; Scheffler K; Bones J
Eur J Pharm Biopharm; 2021 Jan; 158():83-95. PubMed ID: 33212184
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity assessment of antibody-derived therapeutics at the intact and middle-up level by low-flow sheathless capillary electrophoresis-mass spectrometry.
Haselberg R; De Vijlder T; Heukers R; Smit MJ; Romijn EP; Somsen GW; Domínguez-Vega E
Anal Chim Acta; 2018 Dec; 1044():181-190. PubMed ID: 30442400
[TBL] [Abstract][Full Text] [Related]
14. Combination of intact, middle-up and bottom-up levels to characterize 7 therapeutic monoclonal antibodies by capillary electrophoresis - Mass spectrometry.
Giorgetti J; Beck A; Leize-Wagner E; François YN
J Pharm Biomed Anal; 2020 Apr; 182():113107. PubMed ID: 32004767
[TBL] [Abstract][Full Text] [Related]
15. Multiple-parallel-protease digestion coupled with high-resolution mass spectrometry: An approach towards comprehensive peptide mapping of therapeutic mAbs.
Pradhan G; Sneha JM; Sonwane BP; Santhakumari B; Rao A; Kulkarni MJ
J Proteomics; 2021 Feb; 232():104053. PubMed ID: 33238212
[TBL] [Abstract][Full Text] [Related]
16. Integrating Intact Mass Analysis and Middle-Down Mass Spectrometry Approaches to Effectively Characterize Trastuzumab and Adalimumab Structural Heterogeneity.
Zhu W; Li M; Zhang J
J Proteome Res; 2021 Jan; 20(1):270-278. PubMed ID: 33118822
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.
Gahoual R; Biacchi M; Chicher J; Kuhn L; Hammann P; Beck A; Leize-Wagner E; François YN
MAbs; 2014; 6(6):1464-73. PubMed ID: 25484058
[TBL] [Abstract][Full Text] [Related]
18. Middle Level IM-MS and CIU Experiments for Improved Therapeutic Immunoglobulin Subclass Fingerprinting.
Botzanowski T; Hernandez-Alba O; Malissard M; Wagner-Rousset E; Deslignière E; Colas O; Haeuw JF; Beck A; Cianférani S
Anal Chem; 2020 Jul; 92(13):8827-8835. PubMed ID: 32453570
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive characterization of monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometry.
Jin Y; Lin Z; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
MAbs; 2019 Jan; 11(1):106-115. PubMed ID: 30230956
[TBL] [Abstract][Full Text] [Related]
20. Fast, robust and high-resolution glycosylation profiling of intact monoclonal IgG antibodies using nanoLC-chip-QTOF.
Jacobs JF; Wevers RA; Lefeber DJ; van Scherpenzeel M
Clin Chim Acta; 2016 Oct; 461():90-7. PubMed ID: 27458127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
